Curaleaf Holdings, INC 8-K filings

Curaleaf Holdings, Inc. announced the planned release date for its third quarter 2026 financial and operational results, scheduled for November 3, 2026.

Curaleaf Holdings, Inc. has been added to the FTSE Canada All Cap Index, marking its second major Canadian benchmark inclusion.

Curaleaf Holdings, Inc. has published a brochure urging Aurora shareholders to tender their shares, offering a 45% premium and the opportunity to join a leading global cannabis company.

Curaleaf Holdings, Inc. has issued a letter to Aurora Cannabis shareholders, encouraging them to accept its offer, which represents a 45% premium, and become part of the leading global cannabis company.

Curaleaf Holdings, Inc. has applied to the Alberta Securities Commission to halt Aurora's share issuance program, alleging it's an abusive defensive tactic diluting shareholders during Curaleaf's pending offer.

Curaleaf Holdings, Inc. released a fact sheet to counter what it describes as misleading statements from Aurora Cannabis regarding Curaleaf's acquisition proposal.

Curaleaf Holdings, Inc. issued a press release responding to Aurora Cannabis Inc.'s Directors' Circular, reaffirming its offer and criticizing Aurora's financial performance and management decisions.

Curaleaf Holdings, Inc. has formally commenced a take-over bid to acquire all outstanding common shares of Aurora Cannabis Inc., offering a significant premium and aiming to create a global cannabis industry leader.

Curaleaf Holdings announces its intention to launch a take-over bid for Aurora Cannabis, aiming to create the leading global cannabis platform.

Curaleaf Holdings, Inc. announced robust second quarter 2026 results, featuring a 10% year-over-year revenue increase to $340 million, a 50% gross profit margin, and a net income of $12.5 million.